NOV
Stock Forecast, Prediction & Price Target
NOV (NOV) stock Price Target by analysts
$20
Potential upside: 62.86%
NOV price prediction
What is NOV stock analysts` prediction?
NOV stock forecast: Based on 4 Wall Street analysts` predicted price targets for NOV in the last 3 months, the avarage price target is $20, with a high forecast of $NaN. The average price target represents a 62.86% change from the last price of $12.28.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
NOV stock Price Target by analysts
Full breakdown of analysts given NOV price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
David Anderson Barclays | 0% 0/2 | 9 months ago | $12 -2.28% downside | $14.19 | TheFly | Previous targets (1) |
Stephen Gengaro Stifel Nicolaus | 0% 0/1 | 11 months ago | $25 103.58% upside | $16.25 | TheFly | Previous targets (0) |
Phillip Jungwirth BMO Capital | 50% 1/2 | 11 months ago | $20 62.86% upside | $15.93 | TheFly | Previous targets (1) |
Daniel Kutz Morgan Stanley | 0% 0/1 | 12 months ago | $23 87.29% upside | $15.86 | TheFly | Previous targets (0) |
David Anderson Barclays | 0% 0/2 | about 1 year ago | $20 62.86% upside | $19.81 | TheFly | Previous targets (1) |
Unknown Susquehanna | N/A | over 2 years ago | $29 136.15% upside | $23.31 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | about 3 years ago | $19 54.72% upside | $17.53 | Benzinga | N/A |
Unknown Goldman Sachs | N/A | about 3 years ago | $16 30.29% upside | $14.88 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | about 3 years ago | $18 46.57% upside | $14.73 | Benzinga | N/A |
Unknown Barclays | N/A | about 3 years ago | $22 79.15% upside | $21.45 | Benzinga | N/A |
Unknown Barclays | N/A | over 3 years ago | $20 62.86% upside | $18.68 | Benzinga | N/A |
James West Evercore ISI | 100% 1/1 | over 3 years ago | $22 79.15% upside | $16.17 | TipRanks Contributor | Previous targets (0) |
Marc Bianchi Cowen & Co. | 100% 1/1 | over 3 years ago | $19 54.72% upside | $13.49 | StreetInsider | Previous targets (0) |
Connor Lynagh Morgan Stanley | 100% 1/1 | almost 4 years ago | $17 38.43% upside | $14.43 | Investing | Previous targets (0) |
Phillip Jungwirth BMO Capital | 50% 1/2 | about 4 years ago | $15 22.14% upside | $13.15 | TheFly | Previous targets (1) |
Vaibhav Vaishnav Coker Palmer | 100% 1/1 | over 4 years ago | $12 -2.28% downside | $15.46 | TheFly | Previous targets (0) |
NOV Financial Estimates
NOV Revenue Estimates
NOV EBITDA Estimates
NOV Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $5.52B N/A | $7.23B 31.01% | $8.58B 18.59% | Avg: $9.67B Low: $9.44B High: $9.92B avg. 12.73% | Avg: $10.07B Low: $9.82B High: $10.32B avg. 4.16% | Avg: $10.32B Low: $10.06B High: $10.57B avg. 2.45% | Avg: $10.47B Low: $10.20B High: $10.72B avg. 1.38% |
Net Income
% change YoY
| $-245M N/A | $155M 163.26% | $993M 540.64% | Avg: $728.50M Low: $647.11M High: $877.31M avg. -26.63% | Avg: $888.27M Low: $770.18M High: $1.04B avg. 21.93% | Avg: $774.15M Low: $748.85M High: $798.21M avg. -12.84% | Avg: $786.06M Low: $760.37M High: $810.49M avg. 1.53% |
EBITDA
% change YoY
| $153M N/A | $598M 290.84% | $1.00B 67.55% | Avg: $278.69M Low: $272.10M High: $285.85M avg. -72.18% | Avg: $290.29M Low: $283.00M High: $297.24M avg. 4.16% | Avg: $297.43M Low: $289.95M High: $304.54M avg. 2.45% | Avg: $301.55M Low: $293.97M High: $308.76M avg. 1.38% |
EPS
% change YoY
| -$0.63 N/A | $0.4 163.49% | $2.53 532.49% | Avg: $1.87 Low: $1.63 High: $2.21 avg. -26.16% | Avg: $2.33 Low: $1.94 High: $2.63 avg. 24.66% | Avg: $1.95 Low: $1.89 High: $2.01 avg. -16.26% | Avg: $1.98 Low: $1.92 High: $2.04 avg. 1.53% |
Operating Expenses
% change YoY
| $908M N/A | $1.07B 17.84% | $1.18B 10.46% | Avg: $1.47B Low: $1.44B High: $1.51B avg. 24.88% | Avg: $1.53B Low: $1.49B High: $1.57B avg. 4.16% | Avg: $1.57B Low: $1.53B High: $1.61B avg. 2.45% | Avg: $1.59B Low: $1.55B High: $1.63B avg. 1.38% |
FAQ
What is NOV stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -4.00% in 2025-2028.
We have gathered data from 17 analysts. Their low estimate is 647.11M, average is 728.50M and high is 877.31M.
What is NOV stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 5.18% in 2025-2028.
We have gathered data from 16 analysts. Their low revenue estimate is $9.44B, average is $9.67B and high is $9.92B.
What is NOV stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -4.05% in 2025-2028.
We have gathered data from 17 analysts. Their low earnings per share estimate is $1.63, average is $1.87 and high is $2.20.
What is the best performing analyst?
In the last twelve months 4 analysts have been covering NOV stock. The most successful analyst is David Anderson.